- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04942704
Development of Protocols and Methods for Image Processing and Enhancement of Magnetic Resonance Imaging (MRI) Data.
The purpose of the study is to develop new methods for image processing and enhancement of MRI data. Different setting of acquisition parameters used in conventional clinical MRI protocols will be defined, to create "New Protocols".
The specific aim of this study is to assess and to improve the performance of our image processing methods, by comparing diagnostic qualities of images obtained by conventional MRI protocols with those obtained by corresponding New Protocols' and processed by our image enhancement method.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Libi Mori
- Phone Number: +972522260167
- Email: libi@medicvision.com
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77098
- Recruiting
- Houston Medical Imaging
-
Contact:
- Linh Nguyen
- Email: lnguyen@hmixray.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Volunteers for clinical MRI examination
- Patients undergoing clinical MRI examination
- Capable to provide an informed written consent form
Exclusion Criteria:
- Any contraindication to MRI scanning, such as pacemakers or heart rhythm disturbances, permanent cosmetics or certain metallic implants in the body (excluding dental implants).
- Age <18 years old
- Pregnancy
- Claustrophobia
- Decisional incapacity, mentally disabled,
- MRI exam under sedation or monitoring equipment.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Image Signal to Noise Ratio (SNR)
Time Frame: Through study completion, an average of 2 months.
|
Comparing the SNR of images obtained by conventional protocols with the corresponding New Protocols' processed images.
The comparison will be performed by neuroradiologists, using a 7-point Likert-scale.
Where higher the score, better the outcome (1 means unacceptable and 7 means excellent).
|
Through study completion, an average of 2 months.
|
|
Image Resolution
Time Frame: Through study completion, an average of 2 months.
|
Comparing the resolution of images obtained by conventional protocols with the corresponding New Protocols' processed images.
The comparison will be performed by neuroradiologists, using a 7-point Likert-scale.
Where higher the score, better the outcome (1 means unacceptable and 7 means excellent).
|
Through study completion, an average of 2 months.
|
|
MRI contrast
Time Frame: Through study completion, an average of 2 months.
|
Comparing MR contrast of images obtained by conventional protocols with the corresponding New Protocols' processed images.
The comparison will be performed by neuroradiologists, using a 7-point Likert-scale.
Where higher the score, better the outcome (1 means unacceptable and 7 means excellent).
|
Through study completion, an average of 2 months.
|
|
Artifacts
Time Frame: Through study completion, an average of 2 months.
|
Comparing artifacts of images obtained by conventional protocols with the corresponding New Protocols' processed images.
The comparison will be performed by neuroradiologists, using a 7-point Likert-scale.
Where higher the score, better the outcome (1 means unacceptable and 7 means excellent).
|
Through study completion, an average of 2 months.
|
|
Diagnostic quality
Time Frame: Through study completion, an average of 2 months.
|
Comparing diagnostic quality of images obtained by conventional protocols with the corresponding New Protocols' processed images.
The comparison will be performed by neuroradiologists, using a 7-point Likert-scale.
Where higher the score, better the outcome (1 means unacceptable and 7 means excellent).
|
Through study completion, an average of 2 months.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- iQMR_CSP_01-00
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MRI Image Enhancement
-
Hillel Yaffe Medical CenterMedic Vision Imaging SolutionsRecruitingMRI Image EnhancementIsrael
-
Hôpital FribourgeoisActive, not recruitingMRI Image Enhancement | Medical Imaging Data | Contrast AgentSwitzerland
-
University of PennsylvaniaCanon Medical Systems, USARecruitingImage Enhancement | Radiation ProtectionUnited States
-
University of California, San FranciscoRecruitingMRI | MRI Image EnhancementUnited States
-
BayerCompleted
-
Swansea Bay University Health BoardSwansea UniversityNot yet recruitingMRI | Carcinoma | Glioblastoma | Gastric Cancer | Radiotherapy | MRI Image Enhancement | Brain (Nervous System) Cancers | Oesophageal Carcinoma | MRI Scanner Configuration | MRI-guided Adaptive Radiotherapy | Pancreas CarcinomaUnited Kingdom
-
Medy-ToxCompletedPenile Enhancement | Penile Girth EnhancementKorea, Republic of
-
Ludwig-Maximilians - University of MunichNational Institute of Nutrition and Seafood Research, NorwayCompleted
-
AllerganCompleted
-
Nootrobox, Inc.CompletedBiomedical EnhancementNetherlands
Clinical Trials on Non interventional Imaging - MRI
-
Portsmouth Hospitals NHS TrustArdia Digital Health LtdNot yet recruitingChronic Kidney Disease
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)CompletedUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCHIV Infections | Cancer | HPV-Related Malignancy | Anal Cancer | HIV-Associated Malignant Neoplasm | AIDS Related Lymphoma | AIDS-related Kaposi Sarcoma | AIDS-Related MalignancyUnited States, Puerto Rico
-
Universitätsklinikum Hamburg-EppendorfSandozUnknownPsoriasisDenmark, Spain, Germany, Poland
-
Cliniques universitaires Saint-Luc- Université...Recruiting
-
Ohio State University Comprehensive Cancer CenterCompletedHeavy Metal Exposure From VapingUnited States
-
Bristol-Myers SquibbWithdrawnNon-valvular Atrial FibrillationUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)RecruitingProstate CarcinomaUnited States
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterLilly FoundationRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Enrolling by invitationBarrett Esophagus | Esophageal AdenocarcinomaUnited States